![Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition](https://www.spandidos-publications.com/article_images/ol/19/2/ol-19-02-1487-g01.jpg)
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
![Frontiers | Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions Frontiers | Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions](https://www.frontiersin.org/files/Articles/657701/fonc-11-657701-HTML/image_m/fonc-11-657701-g001.jpg)
Frontiers | Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
![Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series - The Lancet Gastroenterology & Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series - The Lancet Gastroenterology &](https://www.thelancet.com/cms/attachment/710a6acd-62ff-47f7-a70b-de6989ef9638/gr1.jpg)
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series - The Lancet Gastroenterology &
![The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse - ScienceDirect The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S193459091100110X-fx1.jpg)